Series C funding round for ADARx Pharmaceuticals raising $200M in August 2023
Series C funding round for ADARx Pharmaceuticals raising $200M in August 2023
| Investor | Firm Type | Partner |
|---|
TCG CrossoverLEAD | Venture Capital | — |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Private | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Hedge Fund | — | |
| Venture Capital | — | |
| Angel | Ed Mathers |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$321M
Top Valuation
-
ADARx Pharmaceuticals raised $200M in a Series C round.
The round was announced on 08/01/23.
The round was led by Ricky Sun, Chen Yu.